Sadra Medical raises $30M for aortic valve replacement
Sadra Medical, which is developing a procedure to replace the aortic valve (for the less medically-savvy, that’s part of your heart), has raised $30 million in a third round of funding. The Campbell, Calif., company dubs its procedure “percutaneous aortic valve replacement,” and it involves placing the prosthetic valve in a patient’s heart by threading a catheter through their arteries. The round was led by Accuitive Medical Ventures, with participation from previous investors Boston Scientific,… Continue Reading
Valve disease treatment co., Sadra, raises $9M
Sadra Medical, a Campbell company developing therapies for aortic valve disease, has raised a $9M first round of round of funding, the company said.
Pequot Ventures co-led the financing, along with the company’s original seed investors Onset Ventures and Schroder Ventures.
As many as three million people in the U.S. have aortic stenosis, the company said, adding that only a small percentage of those are treated with the current standard of care, open-heart surgery using cardiopulmonary… Continue Reading